Zhitong Finance App News, Renfu Pharmaceutical (600079.SH) issued an announcement. The company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (“Yichang Renfu”, the company holds 80% of its shares) recently published HW231019 tablet phase II clinical trial registration information on the drug clinical trial registration and information disclosure platform of the China Drug Administration.

Zhitongcaijing · 11/12/2025 07:49
Zhitong Finance App News, Renfu Pharmaceutical (600079.SH) issued an announcement. The company's holding subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (“Yichang Renfu”, the company holds 80% of its shares) recently published HW231019 tablet phase II clinical trial registration information on the drug clinical trial registration and information disclosure platform of the China Drug Administration.